Coronavirus Latest News
This French firm’s more variant-proof coronavirus vaccine could help in long-term fight against Covid-19
As the battle with Covid-19 rages around the world, a small French biotech has a possible solution for the long-term war against the virus and the rapidly spreading mutations.The company, Valneva SE, has a vaccine that could be more variant-proof, giving it an edge over other shots in what may be an annual campaign against a disease that’s already killed more than 3 million people.The first participant in its phase three trials will be dosed this week. If successful, that could lead to an…
Read the original article at South China Morning Post